Genmab reported DKK22.48B in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Amarin AMRN:US $ 1044.99M 54.74M
Amgen AMGN:US $ 59773M 2766M
AstraZeneca AZN:LN 73641M 8715M
Bayer BAYN:GR € 114427M 4350M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Exelixis EXEL:US $ 2367.27M 176.73M
Fresenius Medical Care FME:GR € 32987M 172M
Galapagos GLPG:NA € 5430.62M 184.44M
Genmab GEN:DC DK 22483M 273M
GlaxoSmithKline GSK:LN 77011M 1068M
GN Store Nord GN:DC DK 17340M 25M
GRIFOLS GRF:SM € 16213.05M 75.45M
H. Lundbeck A/S LUN:DC 34.04B 429M
Hikma Pharmaceutical HIK:LN 4.18B 45M
Immunogen IMGN:US $ 301.45M 44.52M
Insmed INSM:US $ 1.23B 537.39M
Lonza Group LONN:SW 15.16B 732M
Merck MRK:GR € 43145M 746M
Novartis NOVN:VX SF 124015M 2263M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
William Demant Holding WDH:DC 23.58B 1.65B